Post placeholder image
September 18, 2018 in NanOlogy Press Release, Soria

DFB Soria Completes a Phase 2 Clinical Trial of Submicron Particle Paclitaxel Anhydrous Ointment for Actinic Keratosis

Download PDF DFB Soria Completes a Phase 2 Clinical Trial of Submicron Particle Paclitaxel Anhydrous Ointment for Actinic Keratosis Soria investigational drug provides evidence of actinic ke ...

Read More
Post placeholder image
February 14, 2018 in NanOlogy Press Release, Soria

NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial for Cutaneous Metastases and DFB Soria Provides an Update on AK Trial

  Download PDF NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial for Cutaneous Metastases and DFB Soria Provides an Update on AK Trial   New study of submic ...

Read More
Post placeholder image
December 18, 2017 in NanOlogy Press Release, Soria

NanOlogy Announces First Patient Enrolled in a Pancreatic Cancer Phase 2 Clinical Trial of NanoPac® Adding to Trials in Prostate and Ovarian Cancers

  Download PDF NanOlogy Announces First Patient Enrolled in a Pancreatic Cancer Phase 2 Clinical Trial of NanoPac® Adding to Trials in Prostate and Ovarian Cancers NanOlogy chemotherap ...

Read More
Post placeholder image
November 7, 2017 in NanOlogy Press Release, Soria

NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial of NanoPac® for Treatment of Mucinous Cysts of the Pancreas

  Download PDF NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial of NanoPac® for Treatment of Mucinous Cysts of the Pancreas   NanOlogy may offer a nonsurgical trea ...

Read More
Post placeholder image
October 16, 2017 in NanOlogy Press Release, Soria

NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial of NanoPac® for Treatment of Prostate Cancer

  Download PDF NanOlogy™ Announces First Patient Enrolled in a Phase 2 Clinical Trial of NanoPac® for Treatment of Prostate Cancer NanOlogy to Present at BIO Investor Forum on October ...

Read More
Post placeholder image
September 26, 2017 in NanOlogy Press Release, Soria

DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK)

  Download PDF DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK) AK can lead to the second most c ...

Read More